MIR670HG

Across TCGA pan-cancer cohorts, MIR670HG RNA is linked to patient survival in 16 of 34 cancer types, making it the most broadly survival-associated MIR670HG data layer compared with 1 for mutation status.

The strongest signal is observed in cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC), where higher MIR670HG RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated MIR670HG expression acts as an unfavorable survival marker, although some lineages such as PAAD and SARC show a favorable association.

CESC, BLCA, and UVM are the cancer types where MIR670HG RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CESC	DFS	Tertile	III,IV	0.091	0.728	<.001	72	view →
BLCA	DFS	Tertile	IV	0.067	0.480	<.001	54	view →
UVM	DFS	Tertile	III,IV	0.421	1.000	<.001	46	view →
COAD	OS	Tertile	IV	0.039	0.660	<.001	36	view →
THCA	OS	Tertile	II,III,IV	0.209	0.840	.001	30	view →
PAAD	DFS	Median	All	0.366	0.205	.002	28	view →
READ	OS	Tertile	All	0.205	0.693	.029	27	view →
UCEC	OS	Tertile	All	0.864	0.931	.012	18	view →
THYM	OS	Tertile	All	0.593	0.930	.012	12	view →
SARC	DFS	Tertile	All	0.470	0.289	.017	12	view →
LIHC	OS	Tertile	II,III,IV	0.754	0.352	.023	12	view →
STAD	DFS	Tertile	IV	0.520	0.250	.033	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 16 lineages.

MIR670HG–CESC (DFS)

Open the CESC breakdown →